Fluvoxamine attenuates COVID-19 disease
Steven Lippmann, M.D. The coronavirus pandemic caused us some hard times – disruption, devastation, and death. Despite a recent rise in COVID-19 disease incidence, there is a general feeling that the illness is diminishing. There are countermeasures to mitigate its severity: several vaccines, monoclonal antibody therapies, and antiviral agents. Vaccines can induce some immunity, monoclonal […]